Enterococcus raffinosus is a rare isolate in clinical specimens. A case of vertebral osteomyelitis caused by E. raffinosus in an elderly patient is described and confirms this organism to be an opportunistic human pathogen.
penicillin allergy was given, and the therapy was therefore changed to intravenous vancomycin and metronidazole. On the fifth postoperative day, the vertebral body tissue specimens also grew an Enterococcus species. Metronidazole was discontinued when anaerobic cultures were negative. Urine cultures were negative on two occasions. Postoperative progress was slow: an intermittent low-grade fever and shivering episodes persisted, and the C-reactive protein failed to return to normal levels. The patient suffered episodes of cardiac failure and pulmonary embolism and died on the 45th postoperative day, in spite of apparently appropriate antibiotic therapy.
Specimens of bone tissue and swabs taken during the operation were plated onto MacConkey agar (Oxoid, Basingstoke, United Kingdom) incubated at 37°C in air, chocolate agar (Oxoid) incubated at 37°C in air supplemented with 5% CO 2 , and horse blood agar (Oxoid) incubated at 37°C both in air and anaerobically. In addition, brain heart infusion broth (Oxoid) was inoculated and incubated at 37°C in air. After 24 h of incubation, grey, smooth, and entire nonhemolytic colonies, 1 mm in diameter, were evident on all plates and subsequently also isolated from the enrichment broth. On Gram stain, the isolate was found to be a gram-positive coccus, which formed pairs, singles, and short chains. Lancefield group D antiserum produced a positive reaction, while the catalase test was negative. Results of further biochemical characterization as described previously (4) are shown in Table 2 . The identity of the isolate as Enterococcus raffinosus was subsequently confirmed by the Public Health Laboratory Service (Colindale, United Kingdom). Interestingly, the API 20 Strep identification strip (bioMérieux, Marcy l'Etoile, France) profile obtained (5146750) identified the isolate as E. avium with 99.9% probability. PCR amplification of the intraribosomal DNA variable spacer re- E. raffinosus is a recently described species that is occasionally isolated from human clinical specimens (2) . The natural habitat of E. raffinosus is unknown, but the organism has been described to occur among the oropharyngeal flora of domestic cats, second only to E. faecalis (3) . E. raffinosus has been implicated as a cause of endocarditis and has been recovered from a urine specimen and wound swabs, but clinical and microbiological details confirming the ability of this bacterium to cause serious invasive disease have not been published (1, 4, 6) . This report describes a case of vertebral osteomyelitis (VO) caused by E. raffinosus and the microbiological and diagnostic features.
Infections of bone caused by enterococci are rarely reported. Infective discitis due to enterococci has been reported on six previous occasions since 1969, each one associated with advanced age (8) . The patient described herein was also elderly, had underlying medical problems, and may have been immunosuppressed secondary to steroid therapy. VO is almost invariably the result of hematogenous seeding and as such is frequently associated with underlying endocarditis. It is possible that the patient described in this report had underlying E. raffinosus endocarditis; however, there were no peripheral clinical features of endocarditis, and echocardiography was not performed. Negative urine cultures on two occasions make a urinary source unlikely. Two studies have provided epidemiological evidence that colonization with E. raffinosus can be associated with nosocomial acquisition (1). The infection described in this case was community acquired, and the source of the isolate is not known. It is not known if the patient kept any pets.
Identification of the enterococcal species was complicated by misidentification by the API 20 Strep system, not because the biochemical reactions were inconsistent with this organism but because E. raffinosus is not included in the database for this product. The system identified the isolate as E. avium, and although this error would not have affected patient treatment, it would have affected any epidemiological study that subsequently included this case. The absence of E. raffinosus from the API 20 Strep kit may also have contributed to the paucity of reported infections caused by this species. Empirical treatment for VO is directed towards the most common causes: Staphylococcus aureus and streptococci. Such regimens are frequently ineffective against enterococci, as occurred in this case, highlighting the importance of early invasive sampling to obtain a microbiological diagnosis, particularly in elderly patients. This is the first report of VO caused by E. raffinosus and confirms the pathogenic potential of this bacterium to cause human disease. 
